prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, FINAL DIAGNOSIS: PART 1: LEFT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY -. TWO LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA (0/2) (see comment). PART 2: BREAST, LEFT, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 2 (TUBULE FORMATION 3, NUCLEAR GRADE 2,. MITOTIC RATE 1; TOTAL SCORE 6/9). B. INVASIVE CARCINOMA MEASURES 2.2 CM IN GREATEST DIMENSION. C. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2, SOLID TYPE WITH COMEDONECROSIS. D. DCIS IS PRESENT ADMIXED WITH INVASIVE COMPONENT AND COMPRISES <5% OF TOTAL TUMOR. VOLUME. E. MARGINS OF RESECTION ARE NEGATIVE FOR INVASIVE CARCINOMA AND DCIS, INVASIVE CARCINOMA. IS 5 MM FROM CLOSEST (POSTERIOR) MARGIN OF RESECTION. F. LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. G. SKIN, NEGATIVE FOR TUMOR. H. INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. EQUIVOCAL FOR HER-2/NEU WITH A SCORE OF 2+, AND PER PREVIOUS PATHOLOGY REPORT (. NO AMPLIFICATION OF THE HER-2/NEU GENE WAS SEEN BY INTERFACE FISH ANALYSIS. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2.2 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: DCIS admixed with invasive carcinoma. Percent of tumor occupied by in situ component: 5 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 5 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: Keratin stain. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pNO(i-). M STAGE, PATHOLOGIC: pma. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.

expanded version (tokens=1128) : 
 1. Histological classification:
The breast pathology report indicates that there is invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS). The IDC is classified as Nottingham Grade 2, which is based on tubule formation, nuclear grade, and mitotic activity.

2. Subtype:
The subtype of the breast cancer is LumB.

3. Necrosis:
The histological report mentions that there is comedonecrosis present in the DCIS component.

4. Tumor infiltrating lymphocytes:
There is no specific mention of tumor-infiltrating lymphocytes in the report.

5. Histological grade and nuclear grade:
As per the report, the histological grade is Nottingham Grade 2, and the nuclear grade of the IDC is 2.

6. Lymphovascular invasion:
The histological report indicates that there is lymphovascular space invasion (LVI) present in the tumor.

7. Calcification:
The pathology report mentions that there is calcification present, but does not provide details on the type or extent.

8. Receptor status:
The invasive tumor cells are positive for estrogen receptors (ER) and progesterone receptors (PR). However, HER2/NEU testing is equivocal with a score of 2+. According to the previous pathology report, there was no amplification of the HER2/NEU gene seen through interface FISH analysis.

9. Ancillary testing results:
There is no additional information provided on other

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1279) : 
 The breast pathology report reveals a LumB subtype with invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS) present. The IDC is classified as Nottingham Grade 2 with lymphovascular space invasion identified. ER and PR receptors are positive, HER2/NEU testing is equivocal. DCIS admixed with the invasive component occupies less than 5% of the tumor volume. The margins of resection are negative for invasive carcinoma and DCIS, and calcification is present.

